Cargando…
Clinicopathological characteristics and treatment outcome in obese patients with diffuse large B-cell lymphoma
BACKGROUND: Aberrant MYC and BCL2 expression, cell of origin (COO), and National Comprehensive Cancer Network international prognostic index (NCCN-IPI) are commonly used for risk assessment and treatment decision in patients with diffuse large B-cell lymphoma (DLBCL). Although obesity has been shown...
Autores principales: | Wu, Yu-Ying, You, Jie-Yu, Huang, Cih-En, Hsu, Chia-Chen, Chen, Yi-Yang, Tsou, Hsing-Yi, Chen, Ying-Ju, Li, Chian-Pei, Lai, Yi-Hua, Lu, Chang-Hsien, Chen, Ping-Tsung, Chen, Chih-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797893/ https://www.ncbi.nlm.nih.gov/pubmed/35117223 http://dx.doi.org/10.21037/tcr-20-1362 |
Ejemplares similares
-
The Genomic Landscape in Philadelphia-Negative Myeloproliferative Neoplasm Patients with Second Cancers
por: Hsu, Chia-Chen, et al.
Publicado: (2022) -
Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN
por: Wang, Ying-Hsuan, et al.
Publicado: (2023) -
P984: DIFFERENTIAL IMPACTS OF DISTINCT MUTATION SUBTYPES ON ALTERED S100A8 EXPRESSION AND PHENOTYPIC HETEROGENEITY IN CALR-MUTANT MPN
por: Chen, Ying-Ju, et al.
Publicado: (2023) -
Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study
por: Wang, Ming-Chung, et al.
Publicado: (2018) -
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms
por: Chen, Chih-Cheng, et al.
Publicado: (2017)